These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 26563944
1. Production of Irbesartan Nanocrystals by High Shear Homogenisation and Ultra-Probe Sonication for Improved Dissolution Rate. Sridhar K, Rahman H, Sosnik A, Mukherjee U, Natarajan T, Siram K, Krishnamoorthy B. Curr Drug Deliv; 2016; 13(5):688-97. PubMed ID: 26563944 [Abstract] [Full Text] [Related]
2. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin. Hirlekar R, Kadam V. AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492 [Abstract] [Full Text] [Related]
3. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Dudhipala N, Veerabrahma K. Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287 [Abstract] [Full Text] [Related]
4. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S, Reddy VA, Arora S, Patel K. Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [Abstract] [Full Text] [Related]
8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C. Int J Pharm; 2014 Jun 05; 467(1-2):27-33. PubMed ID: 24680963 [Abstract] [Full Text] [Related]
10. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology. Liu G, Zhang D, Jiao Y, Zheng D, Liu Y, Duan C, Jia L, Zhang Q, Lou H. Int J Pharm; 2012 Jan 17; 422(1-2):516-22. PubMed ID: 22119965 [Abstract] [Full Text] [Related]
11. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS, Elnaggar YS, Abdallah OY. Int J Pharm; 2013 Sep 15; 454(1):462-71. PubMed ID: 23830765 [Abstract] [Full Text] [Related]
12. Preparation and characterization of quercetin nanocrystals. Sahoo NG, Kakran M, Shaal LA, Li L, Müller RH, Pal M, Tan LP. J Pharm Sci; 2011 Jun 15; 100(6):2379-90. PubMed ID: 21491450 [Abstract] [Full Text] [Related]
13. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Kumar BS, Saraswathi R, Kumar KV, Jha SK, Venkates DP, Dhanaraj SA. Drug Deliv; 2014 May 15; 21(3):173-84. PubMed ID: 24102185 [Abstract] [Full Text] [Related]
14. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T, Sandhu HK, Talele TT, Serajuddin AT. Pharm Res; 2016 Jun 15; 33(6):1456-71. PubMed ID: 26951566 [Abstract] [Full Text] [Related]
17. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation. Zhong L, Zhu X, Luo X, Su W. AAPS PharmSciTech; 2013 Jun 15; 14(2):541-50. PubMed ID: 23430728 [Abstract] [Full Text] [Related]
18. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods. Sarnes A, Østergaard J, Jensen SS, Aaltonen J, Rantanen J, Hirvonen J, Peltonen L. Eur J Pharm Sci; 2013 Nov 20; 50(3-4):511-9. PubMed ID: 23999036 [Abstract] [Full Text] [Related]
19. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Ige PP, Baria RK, Gattani SG. Colloids Surf B Biointerfaces; 2013 Aug 01; 108():366-73. PubMed ID: 23602990 [Abstract] [Full Text] [Related]
20. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. Lai F, Pini E, Angioni G, Manca ML, Perricci J, Sinico C, Fadda AM. Eur J Pharm Biopharm; 2011 Nov 01; 79(3):552-8. PubMed ID: 21820052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]